- Our Doctors
- Dr Mei Chan
Dr Mei Chan
MBChB, FRACP, Medical Oncologist
Languages spoken
English, Mandarin
Overview
Centres
Clinical interests
Dr Mei Chan is a medical oncologist who completed her medical degree at the University of Manchester, followed by internship training in the United Kingdom before relocating to Adelaide. She undertook specialist training in medical oncology across several major metropolitan hospitals in South Australia and was awarded Fellowship of the Royal Australasian College of Physicians in 2024.
Dr Chan further advanced her clinical and research expertise through a fellowship at The Queen Elizabeth Hospital, where she focused on gastrointestinal cancer research and was actively involved in early-phase clinical trials aimed at advancing oncology care. She remains engaged in research, with multiple peer-reviewed publications, and contributes to both undergraduate and postgraduate medical education and training.
Dr Chan embraces a holistic approach to cancer care. She finds deep fulfilment in supporting patients and their families throughout the cancer journey, ensuring care is tailored to individual needs. She treats a broad range of solid tumour malignancies.
She consults privately at St Andrews Medical Centre and holds a public appointment at The Queen Elizabeth Hospital.
Clinical interests
Mei's main areas of interest include gastrointestinal cancers (including bowel, stomach, oesophageal, and pancreatic cancer), breast cancer, and lung cancer.
Publications
- Chan, M., Krishnan, T., Townsend, A., Karapetis, C., Roy, A., Foo, T., ... & Price, T. (2025). The current landscape of neoadjuvant therapy for resectable colon cancer. Expert Review of Anticancer Therapy, (just-accepted).
- Chan, M. M., Winter, J. M., Pedersen, S. K., Roy, A. C., Watson, D. I., Hussey, D., ... & Symonds, E. L. (2022). Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a potential diagnostic and prognostic biomarker in esophagogastic cancers.
- Chan, M. M., Hocking, C., Joshi, R., Patel, D., Singhal, N., McGregor, M., ... & Kwatra, V. (2020, November). A shift towards virtual multidisciplinary tumour board meeting during COVID 19 pandemic-A South Australian Survey. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 16, pp. 167-167). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY..
- Rico, G. T., Chan, M. M., & Loo, K. F. (2020). The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence. Cancer Treatment Reviews, 86, 102011.
- Chan, M. M., & Rico, G. T. (2019). The “pet effect” in cancer patients: Risks and benefits of human-pet interaction. Critical reviews in oncology/hematology, 143, 56-61.
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.